$6.99
Price
$2.5B
Market Cap
—
P/E Ratio
-466.0
Forward P/E
$-0.44
EPS (TTM)
—
Dividend Yield
$661M
Cash
$57M
Total Debt
350M
Shares Out
$2.87
$9.75
52-Week Range
Institutional Ownership of Nuvation Bio Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 1.3M | $7M | $10.87 | -43.72% |
Trading Activity for Nuvation Bio Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -66.7% | 1.3M | $5M | $5.62 | |
| 2023-Q1 | |||||
| SELL | EXIT | — | — | $2.06 | |
| 2022-Q4 | |||||
| SELL | -53.9% | 4.8M | $9M | $1.99 | |
| 2022-Q2 | |||||
| SELL | -0.2% | 10.4M | $34M | $4.14 | |
| 2022-Q1 | |||||
| BUY | +21.1% | 10.4M | $55M | $5.40 | |
| 2021-Q1 | |||||
| BUY | NEW | 8.6M | $82M | $10.87 | |
| BUY | NEW | 3.8M | $34M | $10.87 | |
Insider Trading for Nuvation Bio Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.